Why it matters now
The market for glucose monitoring is expanding beyond traditional prescription-based models, driven by increased health awareness and the availability of OTC options. This shift is attracting new consumer segments, including individuals seeking proactive health management rather than solely diabetes management. For device manufacturers, pharmacies, and health retailers, understanding these new buyer profiles and the associated margin structures is crucial for capitalizing on growth opportunities. The evolving regulatory landscape and technological advancements are further accelerating this transformation, requiring a fresh look at market strategies.
Who is exposed
Diabetes device manufacturers face opportunities to expand their customer base but also potential pressure on traditional margins. Pharmacies and health retailers can gain new revenue streams from increased OTC sales, but may need to adjust their merchandising and customer support. The entire diabetes management ecosystem is subject to re-evaluation as self-monitoring becomes more accessible. Revenue and distribution models are shifting.
Most relevant for: Head of Commercial Strategy, Product Manager, Retail Partnerships Lead
What this Viewpoint covers
- Which new consumer segments are driving demand for OTC glucose monitors?
- How do the purchasing behaviors and needs of these new buyers differ from traditional users?
- What are the typical retail margin structures for OTC glucose monitors?
- How might increased competition in the OTC space impact pricing and profitability?
- Which distribution channels are most effectively reaching these new buyer segments?
Signals to watch
- New product launches of OTC glucose monitoring devices.
- Marketing campaigns targeting general wellness or pre-diabetic populations.
- Retail sales data or market reports indicating growth in OTC health categories.
- Changes in regulatory guidance for OTC medical devices.
Decisions it supports
- Developing product features and marketing messages for new OTC glucose monitor buyer segments.
- Optimizing pricing strategies and distribution channels for the OTC market.
- Assessing market entry opportunities or partnership potential in the consumer health space.
How it is built
Prepared after your order from dated public sources - such as medical devices & healthcare filings and announcements, regulatory records, trials, patents and trade data, where relevant - and our market model. Reported facts are cited, estimates are labelled and our assessment is marked as such, following our research method. You receive our verdict, the evidence, who is exposed, the signals to watch and recommended actions, within 24 hours.
Questions
Why are new buyers important for OTC glucose monitors?
New buyer segments represent significant growth opportunities beyond traditional diabetes management. Understanding their needs and purchasing behaviors helps you tailor products and marketing, expanding your market reach and capitalizing on the growing trend of proactive health monitoring.
What kind of data does this Viewpoint use to identify new buyers?
We analyze public information, including consumer health trends, product innovation announcements, and market reports on self-care and wellness devices. This helps us identify emerging user profiles and their motivations for purchasing OTC glucose monitors.
How can this brief help my company capture new market share?
By detailing the characteristics of new buyer segments and the evolving margin landscape, this brief supports targeted product development and marketing strategies. It helps you position your offerings to appeal to a broader consumer base and optimize your commercial approach.